- Report
- July 2024
- 100 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- October 2023
- 156 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- January 2022
- 117 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- January 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- November 2024
- 81 Pages
Global
From €3500EUR$3,929USD£3,035GBP
The Transcranial Doppler (TCD) is a type of ultrasound imaging used to measure the velocity of blood flow in the brain. It is used to detect abnormalities in the blood vessels of the head and neck, such as stenosis, aneurysms, and emboli. It is also used to monitor the effects of certain treatments, such as thrombolysis and carotid endarterectomy. TCD is a non-invasive procedure that does not require the use of radiation or contrast agents.
The TCD market is a subset of the larger ultrasound market, which is estimated to be worth billions of dollars. TCD is used in a variety of clinical settings, including neurology, cardiology, and vascular surgery. It is also used in research settings to study the effects of various treatments on the brain.
The TCD market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Toshiba Medical Systems, and Hitachi Medical Systems. Show Less Read more